Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 3
2020 1
2021 5
2022 3
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Oncogenic Effects of HIV-1 Proteins, Mechanisms Behind.
Isaguliants M, Bayurova E, Avdoshina D, Kondrashova A, Chiodi F, Palefsky JM. Isaguliants M, et al. Among authors: bayurova e. Cancers (Basel). 2021 Jan 15;13(2):305. doi: 10.3390/cancers13020305. Cancers (Basel). 2021. PMID: 33467638 Free PMC article. Review.
Transient and tunable CRISPRa regulation of APOBEC/AID genes for targeting hepatitis B virus.
Kostyushev D, Brezgin S, Kostyusheva A, Ponomareva N, Bayurova E, Zakirova N, Kondrashova A, Goptar I, Nikiforova A, Sudina A, Babin Y, Gordeychuk I, Lukashev A, Zamyatnin AA Jr, Ivanov A, Chulanov V. Kostyushev D, et al. Among authors: bayurova e. Mol Ther Nucleic Acids. 2023 Apr 20;32:478-493. doi: 10.1016/j.omtn.2023.04.016. eCollection 2023 Jun 13. Mol Ther Nucleic Acids. 2023. PMID: 37187708 Free PMC article.
Safety and Immunogenicity of Inactivated Whole Virion COVID-19 Vaccine CoviVac in Clinical Trials in 18-60 and 60+ Age Cohorts.
Gordeychuk IV, Kozlovskaya LI, Siniugina AA, Yagovkina NV, Kuzubov VI, Zakharov KA, Volok VP, Dodina MS, Gmyl LV, Korotina NA, Theodorovich RD, Ulitina YI, Vovk DI, Alikova MV, Kataeva AA, Kalenskaya AV, Solovjeva IV, Tivanova EV, Kondrasheva LY, Ploskireva AA, Akimkin VG, Subbotina KA, Ignatyev GM, Korduban AK, Shustova EY, Bayurova EO, Zhitkevich AS, Avdoshina DV, Piniaeva AN, Kovpak AA, Antonova LP, Rogova YV, Shishova AA, Ivin YY, Sotskova SE, Chernov KA, Ipatova EG, Korduban EA, Ishmukhametov AA. Gordeychuk IV, et al. Among authors: bayurova eo. Viruses. 2023 Aug 29;15(9):1828. doi: 10.3390/v15091828. Viruses. 2023. PMID: 37766235 Free PMC article. Clinical Trial.
Depleting hepatitis B virus relaxed circular DNA is necessary for resolution of infection by CRISPR-Cas9.
Kostyushev D, Kostyusheva A, Brezgin S, Ponomareva N, Zakirova NF, Egorshina A, Yanvarev DV, Bayurova E, Sudina A, Goptar I, Nikiforova A, Dunaeva E, Lisitsa T, Abramov I, Frolova A, Lukashev A, Gordeychuk I, Zamyatnin AA Jr, Ivanov A, Chulanov V. Kostyushev D, et al. Among authors: bayurova e. Mol Ther Nucleic Acids. 2023 Feb 4;31:482-493. doi: 10.1016/j.omtn.2023.02.001. eCollection 2023 Mar 14. Mol Ther Nucleic Acids. 2023. PMID: 36865089 Free PMC article.
Hydroxychloroquine Enhances Cytotoxic Properties of Extracellular Vesicles and Extracellular Vesicle-Mimetic Nanovesicles Loaded with Chemotherapeutics.
Brezgin S, Kostyusheva A, Ponomareva N, Bayurova E, Kondrashova A, Frolova A, Slatinskaya O, Fatkhutdinova L, Maksimov G, Zyuzin M, Gordeychuk I, Lukashev A, Makarov S, Ivanov A, Zamyatnin AA Jr, Chulanov V, Parodi A, Kostyushev D. Brezgin S, et al. Among authors: bayurova e. Pharmaceutics. 2023 Feb 5;15(2):534. doi: 10.3390/pharmaceutics15020534. Pharmaceutics. 2023. PMID: 36839856 Free PMC article.
Immunization with recombinant ORF2 p551 protein protects common marmosets (Callithrix jacchus) against homologous and heterologous hepatitis E virus challenge.
Gordeychuk I, Kyuregyan K, Kondrashova A, Bayurova E, Gulyaev S, Gulyaeva T, Potemkin I, Karlsen A, Isaeva O, Belyakova A, Lyashenko A, Sorokin A, Chumakov A, Morozov I, Isaguliants M, Ishmukhametov A, Mikhailov M. Gordeychuk I, et al. Among authors: bayurova e. Vaccine. 2022 Jan 3;40(1):89-99. doi: 10.1016/j.vaccine.2021.11.042. Epub 2021 Nov 24. Vaccine. 2022. PMID: 34836660 Free article.
Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates.
Tukhvatulin AI, Gordeychuk IV, Dolzhikova IV, Dzharullaeva AS, Krasina ME, Bayurova EO, Grousova DM, Kovyrshina AV, Kondrashova AS, Avdoshina DV, Gulyaev SA, Gulyaeva TV, Moroz AV, Illarionova VV, Zorkov ID, Iliukhina AA, Shelkov AY, Botikov AG, Erokhova AS, Shcheblyakov DV, Esmagambetov IB, Zubkova OV, Tokarskaya EA, Savina DM, Vereveyko YR, Ungur AS, Naroditsky BS, Ishmukhametov AA, Logunov DY, Gintsburg AL. Tukhvatulin AI, et al. Among authors: bayurova eo. Emerg Microbes Infect. 2022 Dec;11(1):2229-2247. doi: 10.1080/22221751.2022.2119169. Emerg Microbes Infect. 2022. PMID: 36031930 Free PMC article.
Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies.
Kozlovskaya LI, Piniaeva AN, Ignatyev GM, Gordeychuk IV, Volok VP, Rogova YV, Shishova AA, Kovpak AA, Ivin YY, Antonova LP, Mefyod KM, Prokosheva LS, Sibirkina AS, Tarasova YY, Bayurova EO, Gancharova OS, Illarionova VV, Glukhov GS, Sokolova OS, Shaitan KV, Moysenovich AM, Gulyaev SA, Gulyaeva TV, Moroz AV, Gmyl LV, Ipatova EG, Kirpichnikov MP, Egorov AM, Siniugina AA, Ishmukhametov AA. Kozlovskaya LI, et al. Among authors: bayurova eo. Emerg Microbes Infect. 2021 Dec;10(1):1790-1806. doi: 10.1080/22221751.2021.1971569. Emerg Microbes Infect. 2021. PMID: 34427172 Free PMC article.
18 results